Congenital dyserythropoietic anemia
MONDO:0019403Congenital dyserythropoietic anemia (CDA) is a heterogenous group of hematological disorders of late erythropoiesis and red cell abnormalities that lead to anemia. Five types of CDA are defined: CDA I, CDA II, CDA III, CDA IV and thrombocytopenia with CDA.
Also known as: CDA, anemia, congenital dyserythropoietic, congenital dyshaematopoietic anaemia, congenital dyshaematopoietic anemia, dyserythropoietic anemia, congenital
14 clinical trials for this condition and its sub-types, 4 tagged with Congenital dyserythropoietic anemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Congenital dyserythropoietic anemia
-
2 sub-types
-
Could a bone drug fix a rare blood disorder?
Disease control Recruiting nowThis early study tests whether zoledronic acid, a drug usually used for bone health, can help people with a rare inherited anemia called congenital dyserythropoietic anemia (CDA). Only 2 adults with CDA who have low hemoglobin or need regular transfusions will receive 4 doses of …
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Massive new registry aims to unlock secrets of rare blood disorder
Knowledge-focused Recruiting nowThis study is a registry for people with Congenital Dyserythropoietic Anemia (CDA), a rare blood disorder. Researchers will collect medical information and blood or bone marrow samples over many years to better understand how the disease progresses, its causes, and how it affects…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to personalize care for rare blood disorders
Knowledge-focused Recruiting nowThis study is for people with sickle cell disease or other rare anemias. Researchers want to use advanced genetic and blood tests to better understand each person's condition. The goal is to make diagnosis more precise so that treatments can be tailored to each patient. About 200…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC